tiprankstipranks
Advertisement
Advertisement

HK:9688 Stock Latest News

Zai Lab Grants New Share Options and RSUs Under 2024 Equity Plan
Company AnnouncementsZai Lab Grants New Share Options and RSUs Under 2024 Equity Plan
9d ago
Zai Lab receives FDA Fast Track Designation for zocilurtatug pelitecan
PremiumThe Fly
Zai Lab receives FDA Fast Track Designation for zocilurtatug pelitecan
10d ago
ZLAB
Zai Lab price target lowered to $44 from $47 at Citi
PremiumThe Fly
Zai Lab price target lowered to $44 from $47 at Citi
13d ago
ZLAB
Zai Lab Files Latest Quarterly Report With U.S. Regulator
PremiumCompany Announcements
Zai Lab Files Latest Quarterly Report With U.S. Regulator
14d ago
Zai Lab Q1 2026 Results Highlight Pipeline Momentum and Upcoming China Launches
PremiumCompany Announcements
Zai Lab Q1 2026 Results Highlight Pipeline Momentum and Upcoming China Launches
14d ago
Zai Lab reports Q1 EPS (4c), consensus (53c)
PremiumThe FlyZai Lab reports Q1 EPS (4c), consensus (53c)
14d ago
ZLAB
Zai Lab Sets 2026 AGM to Reaffirm Board, Auditor and Capital Mandates
Premium
Company Announcements
Zai Lab Sets 2026 AGM to Reaffirm Board, Auditor and Capital Mandates
23d ago
Zai Lab presents new preclinical data on ZL-1503
Premium
The Fly
Zai Lab presents new preclinical data on ZL-1503
1M ago
ZLAB
Zai Lab to present zocilurtatug pelitecan clinical data at AACR meeting
PremiumThe Fly
Zai Lab to present zocilurtatug pelitecan clinical data at AACR meeting
1M ago
ZLAB
Zai Lab Files Preliminary Proxy for 2026 AGM and Seeks New Share Mandates
PremiumCompany Announcements
Zai Lab Files Preliminary Proxy for 2026 AGM and Seeks New Share Mandates
1M ago
Zai Lab Expands Employee Equity Awards Under 2024 Incentive Plan
PremiumCompany Announcements
Zai Lab Expands Employee Equity Awards Under 2024 Incentive Plan
2M ago
Zai Lab, Amgen announces trial agreement to evaluate zocilurtatug pelitecan
PremiumThe Fly
Zai Lab, Amgen announces trial agreement to evaluate zocilurtatug pelitecan
2M ago
AMGN
ZLAB
Zai Lab Narrows Annual Loss as Product Revenue Climbs 15%
PremiumCompany AnnouncementsZai Lab Narrows Annual Loss as Product Revenue Climbs 15%
2M ago
Zai Lab price target lowered to $32 from $39 at JPMorgan
Premium
The Fly
Zai Lab price target lowered to $32 from $39 at JPMorgan
2M ago
ZLAB
Zai Lab Sets Date to Approve Hong Kong-Compliant 2025 Annual Results
Premium
Company Announcements
Zai Lab Sets Date to Approve Hong Kong-Compliant 2025 Annual Results
2M ago
Zai Lab Awards Equity Incentives to CEO Under 2024 Plan
PremiumCompany Announcements
Zai Lab Awards Equity Incentives to CEO Under 2024 Plan
2M ago
Zai Lab: Validated Povetacicept Data and China IgAN Opportunity Support Upside and Buy Rating
PremiumRatings
Zai Lab: Validated Povetacicept Data and China IgAN Opportunity Support Upside and Buy Rating
2M ago
ZLAB
Zai Lab Grants New Equity Awards Under 2024 Incentive Plan
PremiumCompany Announcements
Zai Lab Grants New Equity Awards Under 2024 Incentive Plan
2M ago
Zai Lab Details Board Composition and Committee Roles in Governance Update
PremiumCompany Announcements
Zai Lab Details Board Composition and Committee Roles in Governance Update
3M ago
Zai Lab Grants New Share Options and RSUs Under 2024 Equity Plan
PremiumCompany AnnouncementsZai Lab Grants New Share Options and RSUs Under 2024 Equity Plan
3M ago
Zai Lab Redesignates Leon Moulder as Director in Board Governance Update
Premium
Company Announcements
Zai Lab Redesignates Leon Moulder as Director in Board Governance Update
3M ago
Zai Lab price target lowered to $37 from $55 at Cantor Fitzgerald
Premium
The Fly
Zai Lab price target lowered to $37 from $55 at Cantor Fitzgerald
3M ago
ZLAB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >